These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3451933)

  • 21. [Tumor markers in gynecology. General review].
    Briese V; Strache RR
    Zentralbl Gynakol; 1988; 110(5):257-66. PubMed ID: 3287800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of tumor-associated trypsin inhibitor (TATI) in benign and malignant gynecological tumor].
    Shigemasa K; Hiura M; Ioka A; Yokoyama T; Nogawa T; Chiba T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):256-7. PubMed ID: 8492013
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mucoid carcinoma antigen--a new tumor marker].
    Bieglmayer C; Szepesi T; Neunteufel W
    Gynakol Rundsch; 1988; 28 Suppl 2():203-5. PubMed ID: 3234919
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical significance of SCC antigen assay as a tumor marker].
    Kato H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1057-9. PubMed ID: 2192106
    [No Abstract]   [Full Text] [Related]  

  • 25. [Carcinoma of the ovary: reliability of its markers].
    Moggian G; Gunelli R; Magrone F; Canali P; Spadazzi AP; Pini PL
    Minerva Ginecol; 1988 Jan; 40(1):9-13. PubMed ID: 3163780
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tumor markers for cancer of the uterine cervix].
    Numa F
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():109-12. PubMed ID: 15535216
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors].
    Suzuki M; Sekiguchi I; Tamada T; Sakurabayashi I; Kawai T
    Rinsho Byori; 1985 Feb; 33(2):173-7. PubMed ID: 3858562
    [No Abstract]   [Full Text] [Related]  

  • 28. [Problems for tumor markers in gynecological malignancies].
    Li GT
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):2-4. PubMed ID: 18366922
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical significance of Span-1 antigen assay as a tumor marker].
    Satake K; Chung YS; Umeyama K
    Nihon Rinsho; 1990 Feb; 48 Suppl():1053-6. PubMed ID: 2355504
    [No Abstract]   [Full Text] [Related]  

  • 30. [CA50].
    Kawabe T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():645-6. PubMed ID: 16149601
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor markers identified by line immunoelectrophoresis.
    Krøll J; Andersen MM
    Anticancer Res; 1988; 8(3):475-7. PubMed ID: 3164611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D; Hirasawa A; Susumu N
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of a new tumor marker, BCA 225, in breast cancer].
    Ishi K; Kawashima T; Tani M; Yagi Y; Sugiura T; Yamada H; Nanba T
    Rinsho Byori; 1989 Mar; 37(3):301-5. PubMed ID: 2746920
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of the alpha 1----3fucosyltransferase responsible for confering an oncofetal marker on neuroblastoma cells.
    Gillies DR; Foster CS; Glick MC
    Prog Clin Biol Res; 1991; 366():301-7. PubMed ID: 2068147
    [No Abstract]   [Full Text] [Related]  

  • 35. [Value and limitations of neoplasm markers in the diagnosis of pancreatic carcinoma].
    Fabris C; Basso D; Meggiato T; Del Favero G; Fogar P; Panozzo MP; Ferrara C; Scalon P; Naccarato R
    Recenti Prog Med; 1991 Mar; 82(3):166-72. PubMed ID: 2047559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor markers in gynecological cancer].
    Orbo A
    Tidsskr Nor Laegeforen; 1996 Oct; 116(24):2886-8. PubMed ID: 8975404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Carcinoembryonic antigen, Ca 19-9 and Ca 125 antigen levels in the sera of patients with cancer of the stomach].
    Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
    Pol Tyg Lek; 1988 Feb; 43(5):136-9. PubMed ID: 3165528
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serum CA-125 level in patients with gynecologic tumors].
    Abe Y; Ueda G; Yamasaki M; Inoue M; Hiramatsu K; Inoue Y; Saito J; Nishino T
    Rinsho Byori; 1984 Dec; 32(12):1350-4. PubMed ID: 6597876
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antigenic markers of precancer and cancer of the stomach].
    Frank GA; Pugachev KK
    Arkh Patol; 1990; 52(3):72-6. PubMed ID: 2196035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical use of gynaecologic tumour markers.
    Halila H; Alfthan H; Stenman UH
    Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.